The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process

Pope, LE; Marcelletti, JF; Katz, LR; Lin, JY; Katz, DH; Parish, ML; Spear, PG

HERO ID

4929525

Reference Type

Journal Article

Year

1998

Language

English

PMID

9864049

HERO ID 4929525
In Press No
Year 1998
Title The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process
Authors Pope, LE; Marcelletti, JF; Katz, LR; Lin, JY; Katz, DH; Parish, ML; Spear, PG
Journal Antiviral Research
Volume 40
Issue 1-2
Page Numbers 85-94
Abstract n-Docosanol-treated cells resist infection by a variety of lipid-enveloped viruses including the herpesviruses. Previous studies of the mechanism of action demonstrated that n-docosanol inhibits an event prior to the expression of intermediate early gene products but subsequent to HSV attachment. The studies reported here indicate that n-docosanol inhibits fusion of the HSV envelope with the plasma membrane. Evidence suggests that antiviral activity requires a time-dependent metabolic conversion of the compound. Cellular resistance to infection declines after removal of the drug with a t1/2 of approximately 3 h. Reduced expression of viral genes in n-docosanol-treated cells was confirmed by a 70% reduction in expression of a reporter gene regulated by a constitutive promoter inserted into the viral genome. Inhibited release in treated cells of virion-associated regulatory proteins--an immediate post entry event--was indicated by a 75% reduction in the expression of beta-galactosidase in target cells carrying a stably transfected lacZ gene under control of an HSV immediate--early promoter. Finally, the fusion-dependent dequenching of a lipophilic fluorescent probe, octadecyl rhodamine B chloride, inserted into the HSV envelope was significantly inhibited in treated cells. Inhibition of fusion between the plasma membrane and the HSV envelope, and the subsequent lack of replicative events, may be the predominant mechanism for the anti-HSV activity of n-docosanol.
Doi 10.1016/S0166-3542(98)00048-5
Pmid 9864049
Wosid WOS:000077325500007
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English